Characterizing the Immune Response and Neuronal Damage in COVID-19 (Q113891432)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Characterizing the Immune Response and Neuronal Damage in COVID-19 |
clinical trial |
Statements
Characterizing the Immune Response and Neuronal Damage in SARS-CoV-2 Infected Individuals (English)
0 references
5 March 2020
0 references
5 March 2021
0 references
150
0 references
18 year
0 references